health
Compass vows to press on with FDA application despite new trial request
Citing the urgent unmet need for patients with advanced biliary tract cancer, Compass Therapeutics will continue to seek an approval path for its drug after the FDA recommended the biotech conduct a new clinical study.
ONLY AVAILABLE IN PAID PLANS
Read Full ArticleShare this story
Up next
Related Stories
Dad says he went permanently blind
New York Post
I'm a woman in my 20s and I'm not have the sex I want. I know what's holding me back.
Slate
Millions of cancer cases are linked to 5 common infections: study
New York Post
45-year-old man died after ER sent him home without antibiotics, lawsuit says
OregonLive.com
19 Harmless Symptoms That Are Major Medical Red Flags
BuzzFeed